Daré Bioscience, Inc. - DARE
About Gravity Analytica
Recent News
- 09.24.2025 - Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
- 09.24.2025 - Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
- 08.14.2025 - Daré Bioscience, Inc. Q2 2025 Conference Call
- 08.14.2025 - Daré Bioscience, Inc. Q2 2025 Conference Call
- 08.14.2025 - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- 08.14.2025 - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- 08.07.2025 - Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
- 08.07.2025 - Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
- 08.06.2025 - The DARE to PLAY™ Difference
- 08.06.2025 - The DARE to PLAY™ Difference
Recent Filings
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.02.2025 - 8-K Current report
- 09.02.2025 - EX-99.1 EX-99.1
- 08.14.2025 - 8-K Current report
- 08.14.2025 - EX-99.1 EX-99.1
- 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 08.14.2025 - S-8 Securities to be offered to employees in employee benefit plans
- 07.25.2025 - 8-K Current report